Table 2.
The inflammatory markers response induced by 12 weeks of Nordic Walking training
Baseline blood level of vitamin D3 | Baseline mean ± SD | Observed change mean ± SD (%) | Adjusted changea mean ± SD (%) | Adjusted effectb | ||
---|---|---|---|---|---|---|
Mean; CI (%) | Inferencec | |||||
Irisin (ng mL−1) | Less than 20 ng mL−1 | 11 ± 3 | −23 ± 60 | −19 ± 32 | 26 | Moderate ↑** |
More than 20 ng mL−1 | 10 ± 3 | 5 ± 55 | 3 ± 55 | −2 to 63 | ||
HMGB- 1 (ng mL−1) | Less than 20 ng mL−1 | 13 ± 13 | 116 ± 200 | 56 ± 160 | −42 | Moderate ↓** |
More than 20 ng mL−1 | 27 ± 16 | −30 ± 156 | −10 ± 132 | −71 to 15 | ||
IL6 (pg mL−1 | Less than 20 ng mL−1 | 1.0 ± 0.4 | 12 ± 59 | 15 ± 57 | −23 | Moderate ↓** |
More than 20 ng mL−1 | 0.9 ± 0.3 | −10 ± 66 | −11 ± 47 | −44 to 6 | ||
IL10 (pg mL−1) | Less than 20 ng mL−1 | 0.3 ± 0.2 | −11 ± 412 | 1 ± 141 | 10 | Trivial |
More than 20 ng mL−1 | 0.2 ± 0.1 | 34 ± 440 | 11 ± 136 | −40 to 101 | ||
BDNf (ng mL−1) | Less than 20 ng mL−1 | 25 ± 9 | −2 ± 114 | −12 ± 60 | −9 | Small |
More than 20 ng mL−1 | 28 ± 9 | −25 ± 112 | −20 ± 90 | −37 to 33 | ||
Valine (µmol L−1) | Less than 20 ng mL−1 | 76 ± 20 | 11 ± 33 | 8 ± 27 | 0 | Trivial |
More than 20 ng mL−1 | 81 ± 23 | 6 ± 52 | 9 ± 36 | −16 to 20 | ||
Leucine (µmol L−1) | Less than 20 ng mL−1 | 77 ± 22 | 37 ± 68 | 37 ± 37 | −20 | Moderate ↓** |
More than 20 ng mL−1 | 80 ± 34 | 9 ± 61 | 10 ± 53 | −38 to 3 | ||
Isoleucine (µmol L−1) | Less than 20 ng mL−1 | 60 ± 21 | −26 ± 73 | −22 ± 50 | 15 | Small |
More than 20 ng mL−1 | 53 ± 17 | −6 ± 53 | −10 ± 37 | −10 to 46 |
CI—90% confidence interval. All data are percentages, with the exception of baseline values expressed in measurement units. Inferences shown in bold are clear at the 98% level of confidence
HMGB-1 high mobility group box 1; IL6 interleukin 6; IL10 interleukin 10; BDNf brain-derived neurotrophic factor
aAdjusted to overall mean of in baseline blood level of vitamin D3 more and less than 20 ng mL– 1
bAdjusted mean change in women with baseline blood level of vitamin D3 more than 20 ng mL−1 minus adjusted mean change in women with baseline blood level of vitamin D3 less than 20 ng mL– 1
cMagnitude thresholds (for difference in means divided by SD of women with baseline blood level of vitamin D3 more than 20 ng mL−1): < 0.20, trivial; 0.20–0.59, small; 0.60–1.19, moderate; > 1.20, large
↑—Increase; ↓—decrease
Asterisks indicate effects clear at the 5% level and likelihood that the true effect is substantial: **—likely